INBX Valuation

Inhibrx Biosciences Inc

Add to Watchlist

Advanced Chart

23.070

-0.13(-0.560%)1D

Overview
Forecast
Valuation
Earnings

INBX Relative Valuation

INBX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, INBX is overvalued; if below, it's undervalued.

Historical Valuation

Inhibrx Biosciences Inc (INBX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -0.62. The fair price of Inhibrx Biosciences Inc (INBX) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：23.07

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

3.56

P/B

Median3y

1.27

Median5y

1.27

-50.25

FCF Yield

Median3y

-81.36

Median5y

-81.36

Competitors Valuation Multiple

The average P/S ratio for INBX's competitors is 10.65, providing a benchmark for relative valuation. Inhibrx Biosciences Inc Corp (INBX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

INBX.O

Inhibrx Biosciences Inc

Loss

Average P/S: 10.65

333.96M